Related Experiment Video
Updated: May 28, 2026

05:56
Chronic Unpredictable Mild Stress in Rats based on the Mongolian medicine
Published on: October 27, 2023
Cang-Ai Volatile Oil Ameliorates Chronic Unpredictable Mild Stress-Induced Depression-like Symptoms in Rats by
Mingqin Shi1,2,3, Haimei Zhou1, Xiangdian Xiao4
1Key Laboratory of Traditional Chinese Medicine for Prevention and Treatment of Neuropsychiatric Diseases, Yunnan University of Chinese Medicine, Kunming 650500, China.
Pharmaceuticals (Basel, Switzerland)
|May 27, 2026
Summary
Cang-ai volatile oil (CAVO), a traditional Chinese medicine, effectively reduced depression-like behaviors in rats. This study identified the neurotrophin/TrkB signaling pathway as the key mechanism underlying CAVO's antidepressant effects.
Area of Science:
- Neuroscience
- Pharmacology
- Traditional Chinese Medicine
Background:
- Cang-ai volatile oil (CAVO) is a traditional Chinese medicine used for liver soothing and depression alleviation.
- Depression is a prevalent affective disorder with limited effective treatments.
- The precise mechanism of CAVO's antidepressant action remains unclear.
Purpose of the Study:
- To investigate the antidepressant mechanism of CAVO in a rat model of chronic unpredictable mild stress (CUMS).
- To explore how CAVO impacts brain pathology and depressive behaviors.
- To elucidate the molecular pathways involved in CAVO's therapeutic effects.
Main Methods:
- Establishment of a CUMS rat model.
- Administration of CAVO via nebulization.
- Behavioral, histological, metabolomic, and proteomic analyses.
- Molecular validation of identified pathways.
Main Results:
- Inhaled CAVO ameliorated depression-like behaviors and reduced brain pathology in CUMS rats.
- CAVO modulated serum levels of inflammatory cytokines and neurotrophic factors.
- Metabolomic analysis identified biomarkers associated with CAVO's antidepressant effects.
- Key molecular players including TrkB and CREB were implicated in CAVO's action.
Conclusions:
- CAVO exerts antidepressant effects by regulating the neurotrophin/Trk (NT/Trk) signaling pathway.
- These findings highlight CAVO's therapeutic potential for depression.
- The study provides a foundation for developing novel antidepressant treatments based on CAVO.

